HALIFAX, NOVA SCOTIA: Presentations at RSV16, World Vaccine Congress Europe and IDWeek Conferences Highlight Company's Progress in Using DepoVax(TM)-based Agents to Address Respiratory Syncytial Virus (RSV) and Life-T ...
EDMONTON, ALBERTA: Ceapro Enters into a multi-partners' project through Alberta-Germany Collaboration Fund for Product Development and Commercialization of PGX Technology
...
SYDNEY, AUSTRALIA: New Molecular Assay Is Only Commercial Test to Detect Both M. genitalium and Antibiotic Resistance for One of the World's Fastest Spreading Sexually Transmitted Diseases
...
Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.